Physical Medicine & Rehabilitation Doctors in Williamsport, PA Accepting Medicare

10 Physical Medicine & Rehabilitation doctors found. Showing 1 - 10

Melissa Michaluk, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 700 High St, Williamsport, PA 17701 Phone: 570-321-2619

Kristen Durrwachter, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1705 Warren Ave, Williamsport, PA 17701 Phone: 570-320-7470

Jahan Hashem, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 700 High St, Williamsport, PA 17701 Phone: 570-321-2619

Ian D Cole, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 700 High St, Williamsport, PA 17701 Phone: 570-321-2619    Fax: 570-321-2670

Miss Samantha Lee Hilsher, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1705 Warren Ave Ste 102, Williamsport, PA 17701 Phone: 570-320-7470    Fax: 570-320-7471

Jeffery Williams, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 700 High St, Williamsport, PA 17701 Phone: 570-321-2619

Dr. Jack Michael Smith, MD Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Grampian Blvd, Williamsport, PA 17701 Phone: 570-326-8457    Fax: 570-320-7989

Leah Bowlin, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 700 High St, Williamsport, PA 17701 Phone: 570-321-2620

Alice Schaeffer, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1705 Warren Ave Ste 102, Williamsport, PA 17701 Phone: 570-320-7470

Dr. Lawrence Steven Tomack, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 700 High St, Williamsport, PA 17701 Phone: 570-321-2619    Fax: 570-321-2670

News Archive

Phase III CLL8 trial shows Rituxan plus FC chemotherapy improves patients with CLL

Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec today announced that three-year follow up of the pivotal Phase III CLL8 trial showed Rituxan plus fludarabine and cyclophosphamide (FC) chemotherapy helped patients in the trial with previously untreated chronic lymphocytic leukemia (CLL) live longer than FC alone.

Avastin and cetuximab extend life of patients with KRAS wild-type advanced bowel cancer

CALGB 80405, a large, independent, phase III study, designed to assess the superiority in overall survival (OS) of cetuximab over Avastin (bevacizumab) when combined with either FOLFOX or FOLFIRI chemotherapy in people with previously untreated, KRAS wild-type advanced (metastatic) bowel cancer has failed to meet this primary endpoint.

Fathers who returned after military service have difficulty connecting with young children

Fathers who returned after military service report having difficulty connecting with young children who sometimes don't remember them, according to a study released this week.

FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI

Arteriocyte, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies, announced today approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.

Researchers to evaluate hygiene robot in the field of elderly care

Researchers at CTF, Service Research Center at Karlstad University, will study how a hygiene robot - an intelligent shower - is perceived and received among care staff and residents in service homes in Karlstad, Sweden.The Health and care administration at Karlstad municipality will, as one of the first municipalities in Sweden, install and evaluate an intelligent shower.

Read more Medical News

› Verified 6 days ago